The Lancelet says, in the new study they published, that by 2050 260 million Americans will have some sort of overweight or ...

New statistics have revealed that one in six 10 to 11-year-olds in Buckinghamshire are obese or severely obese.

Findings reveal that more green space in deprived neighborhoods is associated with lower mortality rates, advocating for ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Researchers at New York University have devised a mathematical approach to predict the structures of crystals—a critical step in developing many medicines and electronic devices—in a matter of ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Several different pieces of data, such as general healthy lifestyle and health care, reveal that Massachusetts is the ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

One in nine 10 to 11-year-olds in Elmbridge are obese or severely obese, new figures show – meaning the area has one of the ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Eli Lilly (LLY) and Company announced detailed results from the Phase 3 SURMOUNT-1 three-year study, the longest completed study to date of ...

The committee called for “swift action” from the Government and NHS England to determine why these checks ... and tackling social deprivation and risk factors like smoking, obesity, drug use and ...